Polydopamine-assisted versatile modification of a nucleic acid probe for intracellular microRNA imaging and enhanced

Aixian Zheng1,2, Xiaolong Zhang1,2, Yanbing Huang1,2

  • 1The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou 350025 P. R. China drjingfeng@126.com.

RSC Advances
|May 11, 2022
PubMed

Insights

This study developed a stable nanoprobe using polydopamine for real-time microRNA imaging and cancer photothermal therapy. The polydopamine modification enhances cellular uptake and therapeutic efficacy.

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Nanotechnology

Background:

  • MicroRNAs are crucial in biological processes, with abnormal levels linked to diseases like cancer.
  • Real-time monitoring of microRNAs in cells aids understanding of their roles and disease diagnosis/treatment.

Purpose of the Study:

  • To develop a versatile nucleic acid probe modification using polydopamine (PDA).
  • To enable intracellular microRNA imaging and enhanced photothermal therapy for cancer.

Main Methods:

  • Covalent linkage of thiol-terminated nucleic acid probes to polydopamine via Michael addition in aqueous solution.
  • Utilizing the resulting nanoprobe for intracellular microRNA imaging via fluorescence restoration.
  • Leveraging PDA's photothermal properties for enhanced cancer therapy.

Main Results:

  • The PDA modification yielded a stable nanoprobe with high nucleic acid loading, resistant to hydrolysis.
  • The nanoprobe entered cells effectively without transfection agents.
  • The PDA coating improved photothermal conversion efficiency for effective cancer therapy.

Conclusions:

  • PDA-based versatile modification offers a stable and efficient platform for intracellular microRNA imaging.
  • This approach shows promise for developing combined tumor imaging and photothermal treatment strategies.

Related Concept Videos